Abstract
RNAs form complex structures containing both single-stranded (ss) and double-stranded (ds) regions for their diverse regulatory and catalytic functions. The emerging RNA sequence and structure databases provide the foundation for developing RNA-binding ligands for reprogramming RNA–RNA and RNA–protein interactions through the recognition of RNA sequence and structure. We choose miRNA biogenesis and gene regulation pathways as examples to summarize how chemically modified nucleic acid oligomers can be used to target specific RNA sequences and structures through duplex and triplex formation. We discuss the significant progress that has been made in using anti-miRNA oligonucleotides in targeting mature miRNA by duplex formation. The strategy of targeting dsRNA by triplex formation is relatively less explored. We summarize the recent results of developing nucleobase and backbone modifications in peptide nucleic acids (PNAs) to facilitate structure-specific and selective targeting of dsRNAs over ssRNA and dsDNA at physiological conditions. We briefly discuss how sequence-specific dsRNA-binding PNAs may be utilized to target disease-associated miRNA precursors and viral RNAs.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abes S, Turner JJ, Ivanova GD et al (2007) Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide. Nucleic Acids Res 35:4495–4502
Ahn DG, Kourakis MJ, Rohde LA et al (2002) T-box gene tbx5 is essential for formation of the pectoral limb bud. Nature 417:754–758
Amato F, Tomaiuolo R, Nici F et al (2014) Exploitation of a very small peptide nucleic acid as a new inhibitor of miR-509-3p involved in the regulation of cystic fibrosis disease gene expression. Biomed Res Int 2014:610718
Aupeix K, Le Tinévez R, Toulmé J-J (1999) Binding of oligopyrimidines to the RNA hairpin responsible for the ribosome gag-pol frameshift in HIV-1. FEBS Lett 449:169–174
Avitabile C, Saviano M, D’Andrea L et al (2012) Targeting pre-miRNA by peptide nucleic acids: a new strategy to interfere in the miRNA maturation. Artif DNA PNA XNA 3:88–96
Avitabile C, Cimmino A, Romanelli A (2014) Oligonucleotide analogues as modulators of the expression and function of noncoding RNAs (ncRNAs): emerging therapeutics applications. J Med Chem 57:10220–10240
Avitabile C, Accardo A, Ringhieri P et al (2015) Incorporation of naked peptide nucleic acids into liposomes leads to fast and efficient delivery. Bioconjugate Chem 26:1533–1541
Benner SA (2004) Understanding nucleic acids using synthetic chemistry. Acc Chem Res 37:784–797
Boisguérin P, Deshayes S, Gait MJ et al (2015) Delivery of therapeutic oligonucleotides with cell penetrating peptides. Adv Drug Del Rev 87:52–67
Bose D, Jayaraj G, Suryawanshi H et al (2012) The tuberculosis drug streptomycin as a potential cancer therapeutic: inhibition of miR-21 function by directly targeting its precursor. Angew Chem Int Ed 51:1019–1023
Bose D, Nahar S, Rai MK et al (2015a) Selective inhibition of miR-21 by phage display screened peptide. Nucleic Acids Res 43:4342–4352
Bose T, Banerjee A, Nahar S et al (2015b) β,γ-Bis-substituted PNA with configurational and conformational switch: preferred binding to cDNA/RNA and cell-uptake studies. Chem Commun 51:7693–7696
Buchardt O, Egholm M, Berg RH et al (1993) Peptide nucleic acids and their potential applications in biotechnology. Trends Biotechnol 11:384–386
Buchini S, Leumann CJ (2004) Stable and selective recognition of three base pairs in the parallel triple-helical DNA binding motif. Angew Chem Int Ed 43:3925–3928
Cao S-Q, Okamoto I, Tsunoda H et al (2011) Synthesis and triplex-forming properties of oligonucleotides containing thio-substituted C-nucleoside 4-thiopseudoisocytidine. Tetrahedron Lett 52:407–410
Cartegni L, Krainer AR (2003) Correction of disease-associated exon skipping by synthetic exon-specific activators. Nat Struct Biol 10:120–125
Cassidy SA, Slickers P, Trent JO et al (1997) Recognition of GC base pairs by triplex forming oligonucleotides containing nucleosides derived from 2-aminopyridine. Nucleic Acids Res 25:4891–4898
Cech TR, Steitz JA (2014) The noncoding RNA revolution—trashing old rules to forge new ones. Cell 157:77–94
Chan JA, Krichevsky AM, Kosik KS (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65:6029–6033
Chen DL, McLaughlin LW (2000) Use of pK a differences to enhance the formation of base triplets involving C−G and G−C base pairs. J Org Chem 65:7468–7474
Cheng CJ, Saltzman WM (2012) Polymer nanoparticle-mediated delivery of microRNA inhibition and alternative splicing. Mol Pharm 9:1481–1488
Cheng CJ, Bahal R, Babar IA et al (2015) MicroRNA silencing for cancer therapy targeted to the tumour microenvironment. Nature 518:107–110
Chenoweth DM, Meier JL, Dervan PB (2013) Pyrrole-imidazole polyamides distinguish between double-helical DNA and RNA. Angew Chem Int Ed 52:415–418
Chirayil S, Chirayil R, Luebke KJ (2009) Discovering ligands for a microRNA precursor with peptoid microarrays. Nucleic Acids Res 37:5486–5497
Conrad NK (2014) The emerging role of triple helices in RNA biology. Wiley Interdiscip Rev RNA 5:15–29
Corradini R, Sforza S, Tedeschi T et al (2011) Peptide nucleic acids with a structurally biased backbone: updated review and emerging challenges. Curr Top Med Chem 11:1535–1554
Crooke ST, Geary RS (2013) Clinical pharmacological properties of mipomersen (Kynamro), a second generation antisense inhibitor of apolipoprotein B. Br J Clin Pharmacol 76:269–276
Cummins LL, Owens SR, Risen LM et al (1995) Characterization of fully 2′-modified oligoribonucleotide hetero- and homoduplex hybridization and nuclease sensitivity. Nucleic Acids Res 23:2019–2024
Das I, Désiré J, Manvar D et al (2012) A peptide nucleic acid–aminosugar conjugate targeting transactivation response element of HIV-1 RNA genome shows a high bioavailability in human cells and strongly inhibits Tat-mediated transactivation of HIV-1 transcription. J Med Chem 55:6021–6032
Davis S, Lollo B, Freier S et al (2006) Improved targeting of miRNA with antisense oligonucleotides. Nucleic Acids Res 34:2294–2304
Devi G, Yuan Z, Lu Y et al (2014) Incorporation of thio-pseudoisocytosine into triplex-forming peptide nucleic acids for enhanced recognition of RNA duplexes. Nucleic Acids Res 42:4008–4018
Devi G, Zhou Y, Zhong Z et al (2015) RNA triplexes: from structural principles to biological and biotech applications. Wiley Interdiscip Rev RNA 6:111–128
Dragulescu-Andrasi A, Zhou P, He G et al (2005) Cell-permeable GPNA with appropriate backbone stereochemistry and spacing binds sequence-specifically to RNA. Chem Commun 2005:244–246
Egholm M, Christensen L, Dueholm KL et al (1995) Efficient pH-independent sequence-specific DNA binding by pseudoisocytosine-containing bis-PNA. Nucleic Acids Res 23:217–222
Eldrup AB, Dahl O, Nielsen PE (1997) A novel peptide nucleic acid monomer for recognition of thymine in triple-helix structures. J Am Chem Soc 119:11116–11117
Esau C, Davis S, Murray SF et al (2006) miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 3:87–98
Fabani MM, Gait MJ (2008) miR-122 targeting with LNA/2′-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA–peptide conjugates. RNA 14:336–346
Fabani MM, Abreu-Goodger C, Williams D et al (2010) Efficient inhibition of miR-155 function in vivo by peptide nucleic acids. Nucleic Acids Res 38:4466–4475
Faria M, Spiller DG, Dubertret C et al (2001) Phosphoramidate oligonucleotides as potent antisense molecules in cells and in vivo. Nat Biotechol 19:40–44
Feng Y, Zhang X, Graves P et al (2012) A comprehensive analysis of precursor microRNA cleavage by human Dicer. RNA 18:2083–2092
Fletcher S, Honeyman K, Fall AM et al (2007) Morpholino oligomer-mediated exon skipping averts the onset of dystrophic pathology in the mdx mouse. Mol Ther 15:1587–1592
Gaglione M, Milano G, Chambery A et al (2011) PNA-based artificial nucleases as antisense and anti-miRNA oligonucleotide agents. Mol Biosyst 7:2490–2499
Gambari R (2014) Peptide nucleic acids: a review on recent patents and technology transfer. Expert Opin Ther Pat 24:267–294
Ge J, Yu YT (2013) RNA pseudouridylation: new insights into an old modification. Trends Biochem Sci 38:210–218
Geary R, Henry S, Grillone L (2002) Fomivirsen. Clin Pharmacokinet 41:255–260
Gebert LF, Rebhan MA, Crivelli SE et al (2014) Miravirsen (SPC3649) can inhibit the biogenesis of miR-122. Nucleic Acids Res 42:609–621
Gelsinger C, Steinhagen-Thiessen E, Kassner U (2012) Therapeutic potential of Mipomersen in the management of familial hypercholesterolaemia. Drugs 72:1445–1455
Gumireddy K, Young DD, Xiong X et al (2008) Small-molecule inhibitors of microRNA miR-21 function. Angew Chem Int Ed 47:7482–7484
Gupta P, Zengeya T, Rozners E (2011) Triple helical recognition of pyrimidine inversions in polypurine tracts of RNA by nucleobase-modified PNA. Chem Commun 47:11125–11127
Gupta P, Muse O, Rozners E (2012) Recognition of double-stranded RNA by guanidine-modified peptide nucleic acids. Biochemistry 51:63–73
Hansen ME, Bentin T, Nielsen PE (2009) High-affinity triplex targeting of double stranded DNA using chemically modified peptide nucleic acid oligomers. Nucleic Acids Res 37:4498–4507
Hildbrand S, Blaser A, Parel SP et al (1997) 5-Substituted 2-aminopyridine C-nucleosides as protonated cytidine equivalents: increasing efficiency and selectivity in DNA triple-helix formation. J Am Chem Soc 119:5499–5511
Holmes SC, Arzumanov AA, Gait MJ (2003) Steric inhibition of human immunodeficiency virus type-1 Tat-dependent trans-activation in vitro and in cells by oligonucleotides containing 2′-O-methyl G-clamp ribonucleoside analogues. Nucleic Acids Res 31:2759–2768
Huang X-W, Pan J, An X-Y et al (2007) Inhibition of bacterial translation and growth by peptide nucleic acids targeted to domain II of 23S rRNA. J Pept Sci 13:220–226
Hutvagner G, Simard MJ, Mello CC et al (2004) Sequence-specific inhibition of small RNA function. PLoS Biol 2, E98
Järver P, Torres AG, Gait MJ (2014) Synthetic microRNA blocking agents. In: Arbuthnot P, Weinberg MS (eds) Applied RNAi: from fundamental research to therapeutic applications. Caister Academic Press, Norfolk, pp 105–126
Jayaraj GG, Nahar S, Maiti S (2015) Nonconventional chemical inhibitors of microRNA: therapeutic scope. Chem Commun 51:820–831
Jeker LT, Marone R (2015) Targeting microRNAs for immunomodulation. Curr Opin Pharmacol 23:25–31
Kan L-S, Lin WC, Yadav RD et al (1999) NMR studies of the tautomerism in pseudoisocytidine. Nucleosides Nucleotides 18:1091–1093
Kawasaki AM, Casper MD, Freier SM et al (1993) Uniformly modified 2′-deoxy-2′-fluoro phosphorothioate oligonucleotides as nuclease-resistant antisense compounds with high affinity and specificity for RNA targets. J Med Chem 36:831–841
Kierzek E, Ciesielska A, Pasternak K et al (2005) The influence of locked nucleic acid residues on the thermodynamic properties of 2′-O-methyl RNA/RNA heteroduplexes. Nucleic Acids Res 33:5082–5093
Kloosterman WP, Lagendijk AK, Ketting RF et al (2007) Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development. PLoS Biol 5, e203
Koppelhus U, Zachar V, Nielsen PE et al (1997) Efficient in vitro inhibition of HIV-1 gag reverse transcription by peptide nucleic acid (PNA) at minimal ratios of PNA/RNA. Nucleic Acids Res 25:2167–2173
Krutzfeldt J, Rajewsky N, Braich R et al (2005) Silencing of microRNAs in vivo with ‘antagomirs’. Nature 438:685–689
Kurakin A, Jakob Larsen H, Nielsen PE (1998) Cooperative strand displacement by peptide nucleic acid (PNA). Chem Biol 5:81–89
Lamond AI, Sproat BS (1993) Antisense oligonucleotides made of 2′-O-alkyl RNA: their properties and applications in RNA biochemistry. FEBS Lett 325:123–127
Lee RC, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843–854
Lennox KA, Behlke MA (2010) A direct comparison of anti-microRNA oligonucleotide potency. Pharm Res 27:1788–1799
Lennox KA, Owczarzy R, Thomas DM et al (2013) Improved performance of anti-miRNA oligonucleotides using a novel non-nucleotide modifier. Mol Ther Nucleic Acids 2, e117
Li Z, Rana TM (2014) Therapeutic targeting of microRNAs: current status and future challenges. Nat Rev Drug Discov 13:622–638
Li M, Zengeya T, Rozners E (2010) Short peptide nucleic acids bind strongly to homopurine tract of double helical RNA at pH 5.5. J Am Chem Soc 132:8676–8681
Li N, You X, Chen T et al (2013) Global profiling of miRNAs and the hairpin precursors: insights into miRNA processing and novel miRNA discovery. Nucleic Acids Res 41:3619–3634
Lindow M, Kauppinen S (2012) Discovering the first microRNA-targeted drug. J Cell Biol 199:407–412
Liu YP, Schopman NC, Berkhout B (2013) Dicer-independent processing of short hairpin RNAs. Nucleic Acids Res 41:3723–3733
Ma X, Devi G, Qu Q et al (2014) Intracellular delivery of antisense peptide nucleic acid by fluorescent mesoporous silica nanoparticles. Bioconjugate Chem 25:1412–1420
Majlessi M, Nelson NC, Becker MM (1998) Advantages of 2′-O-methyl oligoribonucleotide probes for detecting RNA targets. Nucleic Acids Res 26:2224–2229
Manicardi A, Fabbri E, Tedeschi T et al (2012) Cellular uptakes, biostabilities and anti-miR-210 activities of chiral arginine-PNAs in leukaemic K562 cells. ChemBioChem 13:1327–1337
Manoharan M (1999) 2′-Carbohydrate modifications in antisense oligonucleotide therapy: importance of conformation, configuration and conjugation. Biochim Biophys Acta 1489:117–130
Meister G, Landthaler M, Dorsett Y et al (2004) Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA 10:544–550
Mendell JR, Rodino-Klapac LR, Sahenk Z et al (2013) Eteplirsen for the treatment of Duchenne muscular dystrophy. Ann Neurol 74:637–647
Mitra R, Ganesh KN (2012) Aminomethylene peptide nucleic acid (am-PNA): synthesis, regio-/stereospecific DNA binding, and differential cell uptake of (α/γ, R/S)am-PNA analogues. J Org Chem 77:5696–5704
Miyata K, Tamamushi R, Tsunoda H et al (2009) Synthesis and triplex formation of oligonucleotides containing 8-thioxodeoxyadenosine. Org Lett 11:605–608
Moens U (2009) Silencing viral microRNA as a novel antiviral therapy? J Biomed Biotechnol 2009:419539
Muse O, Zengeya T, Mwaura J et al (2013) Sequence selective recognition of double-stranded RNA at physiologically relevant conditions using PNA-peptide conjugates. ACS Chem Biol 8:1683–1686
Nair JK, Willoughby JL, Chan A et al (2014) Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing. J Am Chem Soc 136:16958–16961
Ng EW, Shima DT, Calias P et al (2006) Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat Rev Drug Discov 5:123–132
Nielsen PE, Egholm M (1999) An introduction to peptide nucleic acid. Curr Issues Mol Biol 1:89–104
Nielsen PE, Egholm M, Berg RH et al (1991) Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science 254:1497–1500
Nikolova EN, Zhou H, Gottardo FL et al (2013) A historical account of Hoogsteen base-pairs in duplex DNA. Biopolymers 99:955–968
Obad S, dos Santos CO, Petri A et al (2011) Silencing of microRNA families by seed-targeting tiny LNAs. Nat Genet 43:371–378
Oh S, Ju Y, Park H (2009) A highly effective and long-lasting inhibition of miRNAs with PNA-based antisense oligonucleotides. Mol Cells 28:341–345
Oh SY, Ju Y, Kim S et al (2010) PNA-based antisense oligonucleotides for microRNAs inhibition in the absence of a transfection reagent. Oligonucleotides 20:225–230
Okamoto I, Seio K, Sekine M (2006) Triplex forming ability of oligonucleotides containing 2′-O-methyl-2-thiouridine or 2-thiothymidine. Bioorg Med Chem Lett 16:3334–3336
Ono A, Ts’o POP, Kan LS (1991) Triplex formation of oligonucleotides containing 2′-O-methylpseudoisocytidine in substitution for 2′-deoxycytidine. J Am Chem Soc 113:4032–4033
Ottosen S, Parsley TB, Yang L et al (2015) In vitro antiviral activity and preclinical and clinical resistance profile of miravirsen, a novel anti-hepatitis C virus therapeutic targeting the human factor miR-122. Antimicrob Agents Chemother 59:599–608
Panyutin IG, Onyshchenko MI, Englund EA et al (2012) Targeting DNA G-quadruplex structures with peptide nucleic acids. Curr Pharm Des 18:1984–1991
Penna E, Orso F, Taverna D (2015) miR-214 as a key hub that controls cancer networks: small player, multiple functions. J Invest Dermatol 135:960–969
Piva R, Spandidos DA, Gambari R (2013) From microRNA functions to microRNA therapeutics: novel targets and novel drugs in breast cancer research and treatment. Int J Oncol 43:985–994
Püschl A, Sforza S, Haaima G et al (1998) Peptide nucleic acids (PNAs) with a functional backbone. Tetrahedron Lett 39:4707–4710
Qi L, Chan TH, Tenen DG et al (2014) RNA editome imbalance in hepatocellular carcinoma. Cancer Res 74:1301–1306
Ranasinghe RT, Rusling DA, Powers VEC et al (2005) Recognition of CG inversions in DNA triple helices by methylated 3H-pyrrolo [2,3-d] pyrimidin-2(7H)-one nucleoside analogues. Chem Commun 2005:2555–2557
Riguet E, Tripathi S, Chaubey B et al (2004) A peptide nucleic acid-neamine conjugate that targets and cleaves HIV-1 TAR RNA inhibits viral replication. J Med Chem 47:4806–4809
Rozners E (2014) Sequence-selective recognition of double-stranded RNA. In: Erdmann VA, Markiewicz WT, Barciszewski J (eds) Chemical biology of nucleic acids, vol 10. Springer Berlin, Heidelberg, pp 167–180
Rusling DA, Powers VEC, Ranasinghe RT et al (2005) Four base recognition by triplex-forming oligonucleotides at physiological pH. Nucleic Acids Res 33:3025–3032
Sacui I, Hsieh W-C, Manna A et al (2015) Gamma peptide nucleic acids: as orthogonal nucleic acid recognition codes for organizing molecular self-assembly. J Am Chem Soc 137:8603–8610
Sahu B, Chenna V, Lathrop KL et al (2009) Synthesis of conformationally preorganized and cell-permeable guanidine-based γ-peptide nucleic acids (γGPNAs). J Org Chem 74:1509–1516
Semenyuk A, Darian E, Liu J et al (2010) Targeting of an interrupted polypurine:polypyrimidine sequence in mammalian cells by a triplex-forming oligonucleotide containing a novel base analogue. Biochemistry 49:7867–7878
Sharma VK, Sharma RK, Singh SK (2014) Antisense oligonucleotides: modifications and clinical trials. Med Chem Commun 5:1454–1471
Shibata C, Otsuka M, Kishikawa T et al (2013) Current status of miRNA-targeting therapeutics and preclinical studies against gastroenterological carcinoma. Mol Cell Ther 1:5
Shiraishi T, Nielsen PE (2014) Cellular delivery of peptide nucleic acids (PNAs). Methods Mol Biol 1050:193–205
Shortridge MD, Varani G (2015) Structure based approaches for targeting non-coding RNAs with small molecules. Curr Opin Struct Biol 30:79–88
Simonson B, Das S (2015) MicroRNA therapeutics: the next magic bullet? Mini Rev Med Chem 15:467–474
Starega-Roslan J, Koscianska E, Kozlowski P et al (2011) The role of the precursor structure in the biogenesis of microRNA. Cell Mol Life Sci 68:2859–2871
Stein CA, Hansen JB, Lai J et al (2010) Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents. Nucleic Acids Res 38, e3
Strobel SA, Cochrane JC (2007) RNA catalysis: ribozymes, ribosomes, and riboswitches. Curr Opin Chem Biol 11:636–643
Suwanmanee T, Sierakowska H, Fucharoen S et al (2002) Repair of a splicing defect in erythroid cells from patients with beta-thalassemia/HbE disorder. Mol Ther 6:718–726
Toh D-FK, Devi G, Patil KM et al (2016) Incorporating a guanidine-modified cytosine base into triplex-forming PNAs for the recognition of a C-G pyrimidine-purine inversion site of an RNA duplex. Nucleic Acids Res, Submitted
Torres AG, Fabani MM, Vigorito E et al (2011a) MicroRNA fate upon targeting with anti-miRNA oligonucleotides as revealed by an improved Northern-blot-based method for miRNA detection. RNA 17:933–943
Torres AG, Threlfall RN, Gait MJ (2011b) Potent and sustained cellular inhibition of miR-122 by lysine-derivatized peptide nucleic acids (PNA) and phosphorothioate locked nucleic acid (LNA)/2′-O-methyl (OMe) mixmer anti-miRs in the absence of transfection agents. Artif DNA: PNA XNA 2:71–78
Torres AG, Fabani MM, Vigorito E et al (2012) Chemical structure requirements and cellular targeting of microRNA-122 by peptide nucleic acids anti-miRs. Nucleic Acids Res 40:2152–2167
Turner JJ, Ivanova GD, Verbeure B et al (2005) Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells. Nucleic Acids Res 33:6837–6849
Tycowski KT, Guo YE, Lee N et al (2015) Viral noncoding RNAs: more surprises. Genes Dev 29:567–584
van Rooij E, Kauppinen S (2014) Development of microRNA therapeutics is coming of age. EMBO Mol Med 6:851–864
Velagapudi SP, Vummidi BR, Disney MD (2015) Small molecule chemical probes of microRNA function. Curr Opin Chem Biol 24:97–103
Verma S, Eckstein F (1998) Modified oligonucleotides: synthesis and strategy for users. Annu Rev Biochem 67:99–134
Voit T, Topaloglu H, Straub V et al (2014) Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study. Lancet Neurol 13:987–996
von Krosigk U, Benner SA (1995) pH-independent triple helix formation by an oligonucleotide containing a pyrazine donor-donor-acceptor base. J Am Chem Soc 117:5361–5362
Wang G, Xu XS (2004) Peptide nucleic acid (PNA) binding-mediated gene regulation. Cell Res 14:111–116
Wexselblatt E, Esko JD, Tor Y (2014) On guanidinium and cellular uptake. J Org Chem 79:6766–6774
Wightman B, Ha I, Ruvkun G (1993) Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75:855–862
Wilson RC, Doudna JA (2013) Molecular mechanisms of RNA interference. Annu Rev Biophys 42:217–239
Xiang G, Soussou W, McLaughlin LW (1994) A new pyrimidine nucleoside (m5oxC) for the pH-independent recognition of G-C base pairs by oligonucleotide-directed triplex formation. J Am Chem Soc 116:11155–11156
Xiang G, Bogacki R, McLaughlin LW (1996) Use of a pyrimidine nucleoside that functions as a bidentate hydrogen bond donor for the recognition of isolated or contiguous G-C base pairs by oligonucleotide-directed triplex formation. Nucleic Acids Res 24:1963–1970
Yang W, Chendrimada TP, Wang Q et al (2006) Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Nat Struct Mol Biol 13:13–21
Yaroslavsky Anastasia I, Smolina Irina V (2013) Fluorescence imaging of single-copy DNA sequences within the human genome using PNA-directed padlock probe assembly. Chem Biol 20:445–453
Yue Y, Liu J, He C (2015) RNA N 6-methyladenosine methylation in post-transcriptional gene expression regulation. Genes Dev 29:1343–1355
Zengeya T, Li M, Rozners E (2011) PNA containing isocytidine nucleobase: synthesis and recognition of double helical RNA. Bioorg Med Chem Lett 21:2121–2124
Zengeya T, Gupta P, Rozners E (2012) Triple-helical recognition of RNA using 2-aminopyridine-modified PNA at physiologically relevant conditions. Angew Chem Int Ed 51:12593–12596
Zengeya T, Gindin A, Rozners E (2013) Improvement of sequence selectivity in triple helical recognition of RNA by phenylalanine-derived PNA. Artif DNA: PNA XNA 4:69–76
Zhou P, Wang M, Du L et al (2003) Novel binding and efficient cellular uptake of guanidine-based peptide nucleic acids (GPNA). J Am Chem Soc 125:6878–6879
Zhou P, Dragulescu-Andrasi A, Bhattacharya B et al (2006) Synthesis of cell-permeable peptide nucleic acids and characterization of their hybridization and uptake properties. Bioorg Med Chem Lett 16:4931–4935
Zhou Y, Kierzek E, Loo ZP et al (2013) Recognition of RNA duplexes by chemically modified triplex-forming oligonucleotides. Nucleic Acids Res 41:6664–6673
Zipeto MA, Jiang Q, Melese E et al (2015) RNA rewriting, recoding, and rewiring in human disease. Trends Mol Med 21:549–559
Acknowledgments
We thank Prof Mike Gait, Prof Xavier Roca, Prof Ding Xiang Liu, Prof Sek-Man Wong, Dr Jiazi Tan, and Prof Souvik Maiti and his group members for critically reading the manuscript. This work was supported by Singapore Ministry of Education Tier 2 research grants MOE2013-T2-2-024 and MOE2015-T2-1-028 to GC.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Patil, K.M., Chen, G. (2016). Recognition of RNA Sequence and Structure by Duplex and Triplex Formation: Targeting miRNA and Pre-miRNA. In: Jurga, S., Erdmann (Deceased), V., Barciszewski, J. (eds) Modified Nucleic Acids in Biology and Medicine. RNA Technologies. Springer, Cham. https://doi.org/10.1007/978-3-319-34175-0_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-34175-0_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-34173-6
Online ISBN: 978-3-319-34175-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)